cambridge & devonshire, LLC

30 broad street
24th floor
new york, new york 10004

NYS Entity Status
ACTIVE

NYS Filing Date
JANUARY 21, 2014

NYS DOS ID#
4516693

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - CAMBRIDGE & DEVONSHIRE, LLC









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • Fit City: Taking Night-Life Cue, Gyms Lower the Lights
    By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017

    Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.

    Source: NYT > Home Page
  • Cambridge BioMarketing Hires Jen Jonsson As Managing Director
    Tuesday Mar 18, 2014

    Cambridge BioMarketing has named Jen Jonsson as its director of operations. Jonsson had previously served as a managing director for operations for The Barbarian Group, overseeing offices in locationssuch as Boston, New York and San Francisco. Jonsson has also worked in various capacities for Rice McVaney Communications, Arnold Worldwide and Razorfish. She is also a former consultant for theGoogle Creative Lab and founder of interactive agency Fuego5.

    Source: Media Post: MAD Boston
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed
  • A Lesson from Cambridge University: 'All White People Are Racist'
    Wednesday Aug 2, 2017

    New horizons in P.C. at Cambridge.

    Source: American Thinker